Rovi completes acquisition of pharmaceutical manufacturing plant in Phoenix, Arizona, following execution of agreement with Bristol Myers Squibb
Link Securities | The company has informed the National Securities Market Commission (CNMV) that it has completed the Asset Purchase Agreement entered into between its subsidiary ROIS Phoenix Inc. and Bristol Myers Squibb (BMS) for the acquisition of a pharmaceutical manufacturing plant located in Phoenix, Arizona (USA), together with a series of assets and liabilities related thereto. The completion of the aforementioned Asset Purchase Agreement took place once the customary…




